Skip to main content
Equibles
RAPP logo

RAPP · Rapport Therapeutics, Inc.

Track RAPP — free

Use RAPP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RAPP

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$47.42 +0.06 (+0.13%) At close · Aug 14
Market Cap
$2.28B
Shares
47.98M

Rapport Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Rapport Therapeutics, Inc. (RAPP) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$24.06M '25 Q1 25-05-08 · $ −$26.73M '25 Q2 25-08-07 · $20.00M −$19.86M '26 Q1 26-05-07 LATEST · $ −$56.62M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Rapport Therapeutics, Inc. Q2 FY2026 Earnings Call
Revenue
$
Diluted EPS
$-1.19
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Rapport Therapeutics, Inc. Q1 FY2026 Earnings Call
Revenue
$20.00M
Diluted EPS
$-0.42
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-10
Rapport Therapeutics, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Rapport Therapeutics, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-0.71
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Rapport Therapeutics, Inc. Q2 FY2025 Earnings Call
Revenue
$
Diluted EPS
$-0.75
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Rapport Therapeutics, Inc. Q1 FY2025 Earnings Call
Revenue
$
Diluted EPS
$-0.68
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-11
Rapport Therapeutics, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Rapport Therapeutics, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.50
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 earnings calls
Key facts CIK 2012593 CUSIP 75383L102 13F (30d) 156 filings 153 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)